메뉴 건너뛰기




Volumn 52, Issue 4, 2003, Pages 346-348

Equivalent single-dose pharmacokinetics of two different dosing methods of prolonged-release fulvestrant ('Faslodex') in postmenopausal women with advanced breast cancer

Author keywords

Advanced breast cancer; Antiestrogen; Estrogen receptor downregulator; Fulvestrant; Pharmacokinetics

Indexed keywords

FULVESTRANT;

EID: 0242267021     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-003-0643-7     Document Type: Article
Times cited : (21)

References (6)
  • 1
    • 0034663421 scopus 로고    scopus 로고
    • ICI 182,780 (Faslodex(tm)): Development of a novel, "pure" antiestrogen
    • Howell A, Osborne CK, Morris C, Wakeling AE (2000) ICI 182,780 (Faslodex(tm)): development of a novel, "pure" antiestrogen. Cancer 89:817
    • (2000) Cancer , vol.89 , pp. 817
    • Howell, A.1    Osborne, C.K.2    Morris, C.3    Wakeling, A.E.4
  • 2
    • 0027344351 scopus 로고
    • The future of new pure antiestrogens in clinical breast cancer
    • Wakeling AE (1993) The future of new pure antiestrogens in clinical breast cancer. Breast Cancer Res Treat 25:1
    • (1993) Breast Cancer Res Treat , vol.25 , pp. 1
    • Wakeling, A.E.1
  • 4
    • 0029883292 scopus 로고    scopus 로고
    • Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines
    • Pink JJ, Jordan VC (1996) Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Res 55:2321
    • (1996) Cancer Res , vol.55 , pp. 2321
    • Pink, J.J.1    Jordan, V.C.2
  • 6
    • 0037102126 scopus 로고    scopus 로고
    • A double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in post-menopausal women with advanced breast cancer progressing on prior endocrine therapy: Results of a North American trial
    • Osborne CK, Pippen J, Jones SE, Parker LM, Ellis M, Come S, Gertler S, May JT, Burton G, Dimery I, Webster A, Morris C, Elledge R, Buzdar A (2002) A double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in post-menopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial. J Clin Oncol 20:3386
    • (2002) J Clin Oncol , vol.20 , pp. 3386
    • Osborne, C.K.1    Pippen, J.2    Jones, S.E.3    Parker, L.M.4    Ellis, M.5    Come, S.6    Gertler, S.7    May, J.T.8    Burton, G.9    Dimery, I.10    Webster, A.11    Morris, C.12    Elledge, R.13    Buzdar, A.14


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.